Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,035	354	216	534	1,478	190
Market Cap Growth	231.11%	63.68%	-59.47%	-63.87%	678.14%	16.11%
Enterprise Value	624	240	177	427	1,306	193
PE Ratio	-	-4.39	-3.05	-81.48	-9.49	-2.20
PS Ratio	17.29	6.06	4.20	12.27	84.92	44.93
PB Ratio	2.54	3.89	6.12	6.07	19.42	-52.32
P/FCF Ratio	-15.53	-4.64	-3.42	-8.00	-27.17	-2.38
P/OCF Ratio	-16.07	-5.04	-3.63	-8.15	-27.59	-2.45
EV/Sales Ratio	10.43	4.11	3.43	9.81	75.07	45.67
EV/EBITDA Ratio	-9.59	-3.61	-2.85	168.19	-8.94	-2.48
EV/EBIT Ratio	-9.27	-3.46	-2.76	3618.88	-8.78	-2.41
EV/FCF Ratio	-10.82	-3.14	-2.79	-6.40	-24.02	-2.42
Debt / Equity Ratio	0.18	0.92	1.82	0.67	0.77	-16.35
Debt / EBITDA Ratio	-0.76	-1.26	-1.04	23.23	-0.40	-0.76
Debt / FCF Ratio	-0.85	-1.09	-1.02	-0.88	-1.07	-0.74
Quick Ratio	21.04	6.41	3.99	7.10	9.08	4.88
Current Ratio	21.39	6.66	4.13	7.26	9.23	5.00
Asset Turnover	0.22	0.35	0.31	0.19	0.13	0.05
Interest Coverage	-7.46	-6.12	-9.12	0.02	-22.00	-13.16
Return on Equity (ROE)	-90.40%	-288.90%	-125.10%	-7.70%	-934.00%	-831.00%
Return on Assets (ROA)	-42.90%	-48.50%	-42.50%	-2.90%	-115.20%	-96.30%
Return on Capital (ROIC)	-18.96%	-47.20%	-78.92%	-53.09%	-46.71%	-154.01%
Earnings Yield	-11.14%	-22.79%	-32.83%	-1.23%	-10.53%	-45.48%
FCF Yield	-8.42%	-21.55%	-29.26%	-12.50%	-3.68%	-42.03%
Buyback Yield / Dilution	-70.60%	-3.57%	-0.59%	-35.24%	-34.19%	-18.78%
Total Shareholder Return	-70.60%	-3.57%	-0.59%	-35.24%	-34.19%	-18.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).